Ironwood Pharmaceuticals | IRWD - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Almirall EUR 429.87M 180.02M 2025-12
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amarin USD 23.17M 961K 2025-12
Ardelyx USD 89.66M 24.7M 2026-03
Astellas Pharma JPY 482.54B 38.28B 2026-06
AstraZeneca USD 12.86B 251M 2026-06
Charles River Laboratories USD 348.78M 69.47M 2026-06
Coherus Biosciences USD 8.7M 853K 2025-12
Halozyme Therapeutics USD 297.47M 75.53M 2026-03
Incyte USD 1.57B 400.89M 2026-06
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
MacroGenics USD 11.24M 19.87M 2026-03
Moderna USD -566M 792M 2026-03
Myriad Genetics USD 146.8M 3M 2025-12
Pacira USD 133.91M 7.27M 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Takeda JPY 813.22B 124.39B 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12